Both in Pharmaceuticals
Gain Therapeutics vs Fortress Biotech
Over the past year GANX returned −7.2% and FBIO returned −43.6%; their daily moves had a correlation of 0.14.
GANX −7.2% FBIO −43.6%Growth of $1, one year, split-adjusted
| Metric | GANX | FBIO |
|---|---|---|
| Price | $1.68 | $2.20 |
| Market cap | $73.3M | $73.4M |
| Today | −5.08% | +1.38% |
| 1 month | −5.1% | −20.6% |
| 6 months | −6.7% | −18.5% |
| Year to date | −47.8% | −39.9% |
| 1 year | −6.1% | −43.7% |
| Revenue growth (YoY) | — | +14.0% |
| Gross margin | — | 67.2% |
| Net margin | — | −13.2% |
| P/E (TTM) | — | 0.7× |
| Price / sales | — | 1.1× |
| Net cash | $12.7M | $157.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.5% | 60.9% |
| Short % of float | 7.1% | 19.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).